ArticleCancers2025

Oncologic Outcomes and Safety of Neoadjuvant Treatment with Anthracyclines Versus Anthracycline-Free Regimens in HER2-Positive Early Breast Cancer in a Colombian Cancer Center: An Observational, Analytical, Retrospective Study.

Alfredo Acevedo-Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.